Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-19-003570
Filing Date
2019-11-13
Accepted
2019-11-13 17:11:30
Documents
2
Period of Report
2019-11-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1614
2 POWER OF ATTORNEY downs_ex2401.htm EX-24.1 4700
  Complete submission text file 0001683168-19-003570.txt   7659
Mailing Address 31700 RESEARCH PARK DRIVE MADISON HEIGHTS MI 48071
Business Address
Downs Christopher (Reporting) CIK: 0001705978 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39126 | Film No.: 191215123

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Issuer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations